Advertisement
Advertisement

HRMY

HRMY logo

Harmony Biosciences Holdings, Inc. Common Stock

28.48
USD
+0.54
+1.91%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

28.48

0.00
+0.02%

Harmony Biosciences Holdings, Inc. Common Stock Profile

About

Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.

Info & Links

CEO

Jeffrey M. Dayno

Headquarters

630 W. Germantown Pike, Suite 215
Plymouth Meeting, PA 19462, UNITED STATES

Sector

Medical

Auditor

Deloitte & Touche LLP

Share holders

43

Employees

268

Harmony Biosciences Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.63B

Enterprise Value

1.36B

Enterprise Value/EBITDA(ttm)

6.38

Price to Earnings Ratio(ttm)

16.54

Price to Sales(ttm)

2.92

Price to Book(mrq)

3.33

Price to Cash(ytd)

13.38

Profitability

Gross Margin(ttm)

78.40%

Operating Margin(ttm)

17.98%

Profit Margin(ttm)

20.21%

Return on Equity(ttm)

23.16%

Return on Invested Capital(ttm)

19.23%

Return on Assets(ttm)

14.24%

Income Statement

Revenue(ttm)

714.73M

Revenue Per Share(ttm)

12.46

Gross Profit(ttm)

557.92M

EBITDA(ttm)3

213.38M

Net Income Available to Common(ttm)

145.49M

Diluted EPS(ttm)

2.11

Share Statistics

Beta (5Y Monthly)

0.80

52-Week Change

-2.45%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.35M

Dividend Yield

0.00%

Float4

39.47M

% Held by Insiders

30.80%

% Held by Institutions

86.23%

Balance Sheet

Total Cash(mrq)

467.19M

Total Cash Per Share(mrq)

8.15

Total Debt(mrq)

179.27M

Total Debt/Equity(mrq)

27.20%

Current Ratio(mrq)

3.31%

Quick Ratio(mrq)

3.20%

Book Value Per Share(mrq)

11.53

Cash Flow

Operating Cash Flow Per Share(ytd)

3.80

Free Cash Flow(ytd)

218.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement